YM-53601, a Novel Squalene Synthase Inhibitor, Reduces Plasma Cholesterol and Triglyceride Levels in Several Animal Species

British Journal of Pharmacology - United States
doi 10.1038/sj.bjp.0703545
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Schisandra Fructus Butanol Fraction Reduces Serum Total Cholesterol and Triglyceride Levels in Hyperlipidemic Mice

The Journal of Internal Korean Medicine
2018English

Metabolic Heterogeneity Associated With High Plasma Triglyceride or Low HDL Cholesterol Levels in Men

Arteriosclerosis and Thrombosis: A Journal of Vascular Biology
1993English

The Squalestatins, Novel Inhibitors of Squalene Synthase Produced by a Species of Phoma. V. Minor Metabolites.

Journal of Antibiotics
Drug DiscoveryPharmacology
1994English

Lapaquistat Acetate: Development of a Squalene Synthase Inhibitor for the Treatment of Hypercholesterolemia

Circulation
Cardiovascular MedicinePhysiologyCardiology
2011English

CJ-15,183, a New Inhibitor of Squalene Synthase Produced by a Fungus, Aspergillus Aculeatus.

Journal of Antibiotics
Drug DiscoveryPharmacology
2001English

Dairy Products and Plasma Cholesterol Levels

Food and Nutrition Research
NutritionDieteticsPublic HealthFood ScienceEnvironmentalOccupational Health
2010English

Dog Age and Breeds Associated With High Plasma Cholesterol and Triglyceride Concentrations

Journal of Veterinary Medical Science
Veterinary
2014English

Experimental Model of Escape Phenomenon in Hamsters and the Effectiveness of YM-53601 in the Model

British Journal of Pharmacology
Pharmacology
2002English

Formation of Petroleum From Squalene and Cholesterol.

The Journal of the Society of Chemical Industry, Japan
1923English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy